Topics

US considering eight years protection for biologicals in China

21:56 EDT 6 Jun 2019 | Generics and Biosimilars Initiative

Makers of copy biologicals in China may be set to get a further boost, as the Trump administration is said to be considering conceding to China’s proposal to shorten the period of protection granted to US drugmakers’ biologicals in the country.

Original Article: US considering eight years protection for biologicals in China

NEXT ARTICLE

More From BioPortfolio on "US considering eight years protection for biologicals in China"

Quick Search